These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26331886)

  • 1. Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development.
    Greenow KR; Smalley MJ
    Curr Protoc Pharmacol; 2015 Sep; 70():14.36.1-14.36.14. PubMed ID: 26331886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes.
    Usary J; Darr DB; Pfefferle AD; Perou CM
    Curr Protoc Pharmacol; 2016 Mar; 72():14.38.1-14.38.11. PubMed ID: 26995547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational therapeutics in genetically engineered mouse models of cancer.
    Olive KP; Politi K
    Cold Spring Harb Protoc; 2014 Feb; 2014(2):131-43. PubMed ID: 24492770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.
    Pfefferle AD; Herschkowitz JI; Usary J; Harrell JC; Spike BT; Adams JR; Torres-Arzayus MI; Brown M; Egan SE; Wahl GM; Rosen JM; Perou CM
    Genome Biol; 2013 Nov; 14(11):R125. PubMed ID: 24220145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine.
    DeRose YS; Gligorich KM; Wang G; Georgelas A; Bowman P; Courdy SJ; Welm AL; Welm BE
    Curr Protoc Pharmacol; 2013 Mar; Chapter 14():Unit14.23. PubMed ID: 23456611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.
    Diaz-Cruz ES; Cabrera MC; Nakles R; Rutstein BH; Furth PA
    Breast Dis; 2010; 32(1-2):85-97. PubMed ID: 21778574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and utility of genetically humanized mouse models.
    Scheer N; Snaith M; Wolf CR; Seibler J
    Drug Discov Today; 2013 Dec; 18(23-24):1200-11. PubMed ID: 23872278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered mouse models in oncology research and cancer medicine.
    Kersten K; de Visser KE; van Miltenburg MH; Jonkers J
    EMBO Mol Med; 2017 Feb; 9(2):137-153. PubMed ID: 28028012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches.
    van Miltenburg MH; Jonkers J
    Curr Opin Genet Dev; 2012 Feb; 22(1):21-7. PubMed ID: 22321988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
    Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
    Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice.
    Wu M; Jung L; Cooper AB; Fleet C; Chen L; Breault L; Clark K; Cai Z; Vincent S; Bottega S; Shen Q; Richardson A; Bosenburg M; Naber SP; DePinho RA; Kuperwasser C; Robinson MO
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7022-7. PubMed ID: 19369208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying drug resistance using genetically engineered mouse models for breast cancer.
    Rottenberg S; Pajic M; Jonkers J
    Methods Mol Biol; 2010; 596():33-45. PubMed ID: 19949919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches.
    Simond AM; Muller WJ
    Adv Cancer Res; 2020; 147():189-228. PubMed ID: 32593401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.
    Roper J; Martin ES; Hung KE
    Curr Protoc Pharmacol; 2014 Jun; 65():14.29.1-10. PubMed ID: 24934606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered mouse models of PI3K signaling in breast cancer.
    Klarenbeek S; van Miltenburg MH; Jonkers J
    Mol Oncol; 2013 Apr; 7(2):146-64. PubMed ID: 23478237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered mouse models of esophageal cancer.
    Mahmoudian RA; Farshchian M; Abbaszadegan MR
    Exp Cell Res; 2021 Sep; 406(2):112757. PubMed ID: 34331909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mouse models of brain cancer and the promise of preclinical testing.
    Huse JT; Holland EC
    Brain Pathol; 2009 Jan; 19(1):132-43. PubMed ID: 19076778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.
    Swiatnicki MR; Andrechek ER
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):231-243. PubMed ID: 31227983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.